The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media

被引:14
作者
Emonts, Marieke
Wiertsema, Selma P.
Veenhoven, Reinier H.
Houwing-Duistermaat, Jeanine J.
Walraven, Vanessa
de Groot, Ronald
Hermans, Peter W. M.
Sanders, Elisabeth A. M.
机构
[1] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Pediat Immunol, Utrecht, Netherlands
[3] Spaarne Hosp, Dept Pediat, Hoofddorp, Netherlands
[4] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen, Netherlands
关键词
plasminogen activator inhibitor-1; polymorphism; otitis media;
D O I
10.1542/peds.2006-1390
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives. Plasminogen activator inhibitor-1 counterregulates cell migration, adhesion, and tissue repair. The PAI1 4G/5G promoter polymorphism has an effect on expression levels of PAI1. After a first acute otitis media episode, children are at increased risk for a next episode. Because the PAI1 4G allele is associated with higher plasminogen activator inhibitor-1 production and, hence, decreased tissue repair, we hypothesize that this allele may contribute to increased recurrence of acute otitis media. Patients and Methods. The PAI1 4G/5G polymorphism was genotyped in 348 Dutch children aged 1 to 7 years who were suffering from recurrent acute otitis media and participating in a randomized, controlled trial and 463 healthy control subjects, representative of the general population. Results. No significant difference in PAI1 genotype distribution between the whole acute otitis media group and control subjects was observed. However, children with the PAI1 4G/4G genotype had an increased risk of more frequent acute otitis media episodes compared with those who were homozygous for the 5G variant, also after correction for cofactors. This finding was attributable to children < 4 years of age. Conclusions. Our findings suggest that the PAI1 4G/4G genotype is associated with an increased risk for the otitis-prone condition, potentially because of impaired healing after a previous otitis media episode.
引用
收藏
页码:E317 / E323
页数:7
相关论文
共 39 条
[1]   WHAT IS AN OTITIS-PRONE CHILD [J].
ALHO, OP ;
KOIVU, M ;
SORRI, M .
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 1991, 21 (03) :201-209
[2]   10-YEAR REVIEW OF OTITIS-MEDIA PATHOGENS [J].
BLUESTONE, CD ;
STEPHENSON, JS ;
MARTIN, LM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (08) :S7-S11
[3]  
Bucková D, 2002, ALLERGY, V57, P446
[4]   Genetic susceptibility to otitis media [J].
Casselbrant, ML ;
Mandel, EM .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 5 (01) :1-4
[5]   The genetic component of middle ear disease in the first 5 years of life [J].
Casselbrant, ML ;
Mandel, EM ;
Rockette, HE ;
Kurs-Lasky, M ;
Fall, PA ;
Bluestone, CD ;
Ferrell, RE .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (03) :273-278
[6]   The heritability of otitis media - A twin and triplet study [J].
Casselbrant, ML ;
Mandel, EM ;
Fall, PA ;
Rockette, HE ;
Kurs-Lasky, M ;
Bluestone, CD ;
Ferrell, RE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (22) :2125-2130
[7]   Gene expression profiles of early pneumococcal otitis media in the rat [J].
Chen, A ;
Li, HS ;
Hebda, PA ;
Zeevi, A ;
Swarts, JD .
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2005, 69 (10) :1383-1393
[8]   Plasminogen activator inhibitor-1 in the pathogenesis of asthma [J].
Cho, SH ;
Ryu, CH ;
Oh, CK .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2004, 229 (02) :138-146
[9]   ACCESSIBILITY OF RECEPTOR-BOUND UROKINASE TO TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR [J].
CUBELLIS, MV ;
ANDREASEN, P ;
RAGNO, P ;
MAYER, M ;
DANO, K ;
BLASI, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) :4828-4832
[10]  
DAWSON SJ, 1993, J BIOL CHEM, V268, P10739